Frequently Asked Questions
The market is segmented based on Thailand Point-of-Care Testing (POCT) Market, By Products (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Diseases Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing, and other POC Products), Application (Blood Glucose Cardiac Monitoring, Hematology, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Non-Invasive Spo2 Monitoring, Non-Invasive Pco2 Monitoring, Blood Transfusion, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Molecular Diagnostics, Immunoassays, and Microfluidics), Prescription Mode (Prescription Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays, and Hematology), End-Users Segment (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgical Centers, Others), Distribution Channel (Direct and Retail Pharmacies) - Industry Trends and Forecast to 2030.
.
The Thailand Point Of Care Testing Poct Market size was valued at USD 139.18 USD Million in 2022.
The Thailand Point Of Care Testing Poct Market is projected to grow at a CAGR of 7.7% during the forecast period of 2023 to 2030.
The market report covers data from the Thailand.
